It’s been a trying time for nearly every industry because of the pandemic. However, it seems as if medtech is rising above these challenges.
Deal activity is up, and more companies seem to be going public. EY’s Annual Pulse of the Industry Report shows these trends and touches on the rise of Special Purpose Acquisition Company (SPAC) mergers.
Jim Welch, EY’s Global MedTech leader, Health Sciences and Wellness division, stops by the Let’s Talk Medtech podcast to break down these trends and discuss what they mean for the industry.